These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7546624)

  • 1. Nitric oxide in cardiovascular diseases.
    Nava E; Noll G; Lüscher TF
    Ann Med; 1995 Jun; 27(3):343-51. PubMed ID: 7546624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular diseases and the nitric oxide pathway.
    Llorens S; Nava E
    Curr Vasc Pharmacol; 2003 Oct; 1(3):335-46. PubMed ID: 15320480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin.
    Nava E; Lüscher TF
    J Hypertens Suppl; 1995 Aug; 13(2):S39-48. PubMed ID: 8576787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vascular nitric oxide in physiological and pathological conditions.
    Marín J; Rodríguez-Martínez MA
    Pharmacol Ther; 1997 Aug; 75(2):111-34. PubMed ID: 9428001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and its role in the cardiovascular system.
    Loscalzo J; Welch G
    Prog Cardiovasc Dis; 1995; 38(2):87-104. PubMed ID: 7568906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitric oxide--a basic mediator of vasodilation and septic shock].
    Vasilev D; Karadimov D; Vogt J; Santak B
    Khirurgiia (Sofiia); 1996; 49(4):14-6. PubMed ID: 8968135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide in the pathogenesis of vascular disease.
    Li H; Förstermann U
    J Pathol; 2000 Feb; 190(3):244-54. PubMed ID: 10685059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide in cardiovascular disorders.
    Dusting GJ
    J Vasc Res; 1995; 32(3):143-61. PubMed ID: 7772676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
    Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
    J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here?
    Bailey A; Pope TW; Moore SA; Campbell CL
    Am J Cardiovasc Drugs; 2007; 7(5):337-45. PubMed ID: 17953472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide. A key mediator in sepsis and endotoxaemia?
    Parratt JR
    J Physiol Pharmacol; 1997 Dec; 48(4):493-506. PubMed ID: 9444603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
    Xu C; Yi C; Wang H; Bruce IC; Xia Q
    Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelium and nitric oxide in childhood hypertension.
    Goonasekera CD; Dillon MJ
    Pediatr Nephrol; 1998 Oct; 12(8):676-89. PubMed ID: 9811394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin.
    Grandel U; Sibelius U; Schrickel J; Schmidt D; Buerke M; Fink L; Bournelis E; Heep M; Mayer K; Bohle RM; Seeger W; Grimminger F
    Crit Care Med; 2001 Jan; 29(1):1-7. PubMed ID: 11176149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide in sepsis and endotoxaemia.
    Parratt JR
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():31-9. PubMed ID: 9511084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.